Literature DB >> 34599434

HIPEC Trials and the US: A Review and Call to Action.

Colette R Pameijer1.   

Abstract

Entities:  

Keywords:  Clinical trial; Colorectal cancer; HIPEC; Metastasis; Peritoneum

Mesh：

Year:  2021        PMID： 34599434     DOI： 10.1245/s10434-021-10769-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  19 in total

Review 1.  Cytoreductive surgery and adjuvant immunotherapy: a new management paradigm for metastatic melanoma.

Authors:  D L Morton; D W Ollila; E C Hsueh; R Essner; R K Gupta
Journal:  CA Cancer J Clin       Date:  1999 Mar-Apr       Impact factor: 508.702

2.  Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study.

Authors:  B Sadeghi; C Arvieux; O Glehen; A C Beaujard; M Rivoire; J Baulieux; E Fontaumard; A Brachet; J L Caillot; J L Faure; J Porcheron; J L Peix; Y François; J Vignal; F N Gilly
Journal:  Cancer       Date:  2000-01-15       Impact factor: 6.860

3.  Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study.

Authors:  O Glehen; F Mithieux; D Osinsky; A C Beaujard; G Freyer; Ph Guertsch; Y Francois; P Peyrat; G Panteix; J Vignal; F N Gilly
Journal:  J Clin Oncol       Date:  2003-03-01       Impact factor: 44.544

4.  Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer.

Authors:  P H Sugarbaker; F J Gianola; J C Speyer; R Wesley; I Barofsky; C E Meyers
Journal:  Surgery       Date:  1985-09       Impact factor: 3.982

5.  Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy.

Authors:  P Jacquet; A D Stephens; A M Averbach; D Chang; S E Ettinghausen; R R Dalton; M A Steves; P H Sugarbaker
Journal:  Cancer       Date:  1996-06-15       Impact factor: 6.860

6.  Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.

Authors:  O Glehen; F Kwiatkowski; P H Sugarbaker; D Elias; E A Levine; M De Simone; R Barone; Y Yonemura; F Cavaliere; F Quenet; M Gutman; A A K Tentes; G Lorimier; J L Bernard; J M Bereder; J Porcheron; A Gomez-Portilla; P Shen; M Deraco; P Rat
Journal:  J Clin Oncol       Date:  2004-08-15       Impact factor: 44.544

7.  Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.

Authors:  Andrew L Feldman; Steven K Libutti; James F Pingpank; David L Bartlett; Tatiana H Beresnev; Sharon M Mavroukakis; Seth M Steinberg; David J Liewehr; David E Kleiner; H Richard Alexander
Journal:  J Clin Oncol       Date:  2003-12-15       Impact factor: 44.544

8.  Peritoneal carcinomatosis from colorectal cancer.

Authors:  D G Jayne; S Fook; C Loi; F Seow-Choen
Journal:  Br J Surg       Date:  2002-12       Impact factor: 6.939

9.  Clinical delivery system for intraperitoneal hyperthermic chemotherapy.

Authors:  J S Spratt; R A Adcock; M Muskovin; W Sherrill; J McKeown
Journal:  Cancer Res       Date:  1980-02       Impact factor: 12.701

10.  Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy.

Authors:  J Esquivel; J Vidal-Jove; M A Steves; P H Sugarbaker
Journal:  Surgery       Date:  1993-06       Impact factor: 3.982
View more
  1 in total

Review 1.  [Current status of surgical treatment of peritoneal metastases from colorectal cancer].

Authors:  Can Yurttas; Markus W Löffler; Alfred Königsrainer; Philipp Horvath
Journal:  Chirurgie (Heidelb)       Date:  2022-08-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.